Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

被引：33
|
作者：
Kosmider, Olivier [1 ]
Passet, Marie [1 ]
Santini, Valeria [2 ]
Platzbecker, Uwe [3 ]
Andrieu, Valerie [4 ]
Zini, Gina [5 ]
Beyne-Rauzy, Odile [6 ]
Guerci, Agnes [7 ]
Masala, Erico [8 ]
Balleari, Enrico [9 ]
Bulycheva, Ekaterina [3 ]
Dreyfus, Francois [10 ]
Fenaux, Pierre [11 ]
Fontenay, Michaela [1 ]
Park, Sophie [12 ]
机构：
[1] Hop Cochin, AP HP, Hematol Biol, Paris, France
[2] Univ Florence, AOU Careggi, Hematol, I-50121 Florence, Italy
[3] Univ Hosp Carl Gustav Dresden, Dresden, Germany
[4] Hop Bichat Claude Bernard, AP HP, Hematol Biol, Paris, France
[5] Univ Cattolica Sacro Cuore, Rome, Italy
[6] Oncopole, IUCT, Toulouse, France
[7] Hop Brabois, Nancy, France
[8] Univ Florence, Florence, Italy
[9] IRCCS AOU San Martino IST Genova, Genoa, Italy
[10] Hop Cochin, Serv Hematol, Paris, France
[11] Hop St Louis, Serv Hematol Seniors, Paris, France
[12] Univ Grenoble Alpes, CHU Grenoble Alpes, Clin Univ Hematol, Grenoble, France
来源：
HAEMATOLOGICA | 2016年 / 101卷 / 07期
关键词：
myelodysplastic syndromes; cytogenetics and molecular genetics; red cells; SURVIVAL; IMPACT; MODEL;
D O I：
10.3324/haematol.2016.142695
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：280 / 283
页数：4
相关论文
共 50 条
  • [11] Role of Erythropoiesis-Stimulating Agents (ESAs) in Supportive Care of Low-Risk Myelodysplastic Syndromes
    Cerchione, Claudio
    Alfinito, Fiorella
    Soriente, Ilaria
    D'Arco, Alfonso Maria
    Danise, Paolo
    Cerciello, Giuseppe
    Pane, Fabrizio
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S324 - S325
  • [12] Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More?
    Komrokji, Rami S.
    Lancet, Jeffrey E.
    List, Alan F.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (01) : 9 - 14
  • [13] Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents
    Park, Sophie
    Hamel, Jean-Francois
    Toma, Andrea
    Kelaidi, Charikleia
    Thepot, Sylvain
    Campelo, Maria Diez
    Santini, Valeria
    Sekeres, Mikkael A.
    Balleari, Enrico
    Kaivers, Jennifer
    Sapena, Rosa
    Goetze, Katharina
    Mueller-Thomas, Catharina
    Beyne-Rauzy, Odile
    Stamatoullas, Aspasia
    Kotsianidis, Ioannis
    Komrokji, Rami
    Steensma, David P.
    Fensterl, Jaime
    Roboz, Gail J.
    Bernal, Teresa
    Ramos, Fernando
    Calabuig, Marisa
    Guerci-Bresler, Agnes
    Bordessoule, Dominique
    Cony-Makhoul, Pascale
    Cheze, Stephane
    Wattel, Eric
    Rose, Christian
    Vey, Norbert
    Gioia, Daniela
    Ferrero, Dario
    Gaidano, Gianluca
    Cametti, Giovanni
    Pane, Fabrizio
    Sanna, Alessandro
    Germing, Ulrich
    Sanz, Guillermo F.
    Dreyfus, Francois
    Fenaux, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (14) : 1591 - +
  • [14] Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents
    Sibon, David
    Cannas, Giovanna
    Baracco, Fiorenza
    Prebet, Thomas
    Vey, Norbert
    Banos, Anne
    Besson, Caroline
    Corm, Selim
    Blanc, Michel
    Slama, Bohrane
    Perrier, Herve
    Fenaux, Pierre
    Wattel, Eric
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (05) : 619 - 625
  • [15] A Systematic Literature Review of Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes
    Boccia, Ralph
    Xiao, Hong
    von Wilamowitz-Moellendorff, Caroline
    Raorane, Renuka
    Deshpande, Sohan
    Klijn, Sven L.
    Yucel, Aylin
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [16] Erythropoiesis in lower-risk myelodysplastic syndromes and beta-thalassemia
    Cappellini, Maria Domenica
    Taher, Ali T.
    Verma, Amit
    Shah, Farrukh
    Hermine, Olivier
    BLOOD REVIEWS, 2023, 59
  • [17] Treatment of anemia with erythroid stimulating agents in myelodysplastic syndromes
    Della Porta, Matteo G.
    LEUKEMIA RESEARCH, 2011, 35 (01) : 22 - 23
  • [18] Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More?
    Rami S. Komrokji
    Jeffrey E. Lancet
    Alan F. List
    Current Hematologic Malignancy Reports, 2010, 5 : 9 - 14
  • [19] Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes
    Itzykson, Raphael
    Kosmider, Olivier
    Fenaux, Pierre
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (04) : 355 - 364
  • [20] Thrombopoiesis-stimulating agents and myelodysplastic syndromes
    Brierley, Charlotte K.
    Steensma, David P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (03) : 309 - 323
12345